Integral Molecular wins COVID-19 NIAID award

By The Science Advisory Board staff writers

April 23, 2020 -- The National Institute of Allergy and Infectious Diseases (NIAID) has awarded Integral Molecular $1 million to help discover vaccines and therapeutics to combat the novel coronavirus.

Integral Molecular will use its Shotgun Mutagenesis Epitope Mapping platform to identify the best antibody candidates to help develop an improved COVID-19 vaccine. The company will also utilize its Membrane Proteome Array platform to identify proteins that allow the novel coronavirus to invade cells. The system has been deployed on other epidemics, including the Zika, Ebola, and Chikungunya viruses.


Copyright © 2020 scienceboard.net
 


Email Address:

First Name:

Last Name:

Learn about ScienceBoard

Get the latest life sciences research and industry news, delivered straight to your inbox, for free.

Why subscribe?

ScienceBoard is uniquely focused on the business of research, addressing the biggest problems that the biomedical industry face. You’ll get breaking news, events coverage, and deep dives into the science that drives innovation, delivered to your inbox daily.

I have read and agree to the privacy policy and terms of service and wish to opt-in for ScienceBoard.net.